Encouragingly, early indicators of anti-glioma activity were observed, including a rapid increase in necrotic tumor volume on MRI, a notable reduction in IL-13Rα2 tumor cell expression, and a promising extension of OS [29]. This evidence concerns the gene IL13RA2 and neoplasm.